pausarir hacia adelante
Subscription to Networkmedica

To access "FDA Extends Review Timeline for Ustekinumab by Three Months" you must have a Networkmedica plan (Pro)

Here you can choose our product line.

NM Extra
Free registration to aquire PDF from NM Extra section


» more details
For a succesful registration follow these steps

A) Mark circle on NMEXTRA US$0
B) Fill the form bellow
C) Follow the steps
Ready
NM Extra - $0
Free
Request a free 3 day trial (type of subscription will be determined by Networkmedica.com)*
» more details
IMPORTANT: the free service will be delivered after analisys by the networkmedica.com staff and approval will be sent via e-mail. We will not accept e-mail addresses from masive mails (hotmail.com, yahoo.com, gmail.com or similar). Only corporate servers.

* This service may be interrupted at any time with no prior notice. Networkmedica.com copyrights reserve
Free 3 day trial - $0
Plus
Daily industry information, Licensees and agreements, Express QTR and Express Rankings, Market Trends, EMEA and FDA Approvals, Legal and Regulatory Information, Archives, Drugs in Depth.
» more details
With the Plus subscription you will have daily access to: News about Clinical Trials (Phase II and III) Advanced Pharmaceutical Pipeline (Phase III) Express QTR (Quarterly Results) within the Pharma and Biotech industry, Express Ranks for the Pharma and Biotech industry, News on Mergers and Acquisitions, Tentative Approvals, Industry Trends, FDA and EMEA Aporovals, EMEA and FDA Panel recommendations, Negative panel recommendations, Patent Challenge, NDA, sNDA, ANDA, IND,BLA, Fast Track, Orphan Drugs, Priority Review and Recalls and Alerts. Three annual reports “Drugs in Depth”.

Daily (Semester) 0,82 US$ (US dollars)

Daily (Annual): 1,09 US$ (US Dollars)
Plus (semester) - $100
Plus (Annual) - $150
Pro
Plus and access to complete Pipelines, Clinical Trials, Vaccines and Bio-similar, Sales and Revenue Charts, Legal and Regulatory Issues, CEOs and more Drugs in Depth.
» more details
By subscribing to NM Pro you will have daily access to NMPlus, news on Clinical Studies (pre-clinical, phase I,II,III and IV) QTR (Quaterlyl results and comparatives) on Pharma, Biotech and Generics, Pharma, Biotech, Vaccines, Bio-similars, Pipeline on Phase I,II,III. Complete Ranks on Pharma and Biotech. CEOs, other markets, Class Actions, Phama and Biotech Appeals for the FDA, US Congress, Blocks (pharma and biotech). “Drugs in Depth” annually*. Access to archives and previous editions.

Daily: 1,91 (U.S. Dollars)


* Monthly
Pro (Annual) - $350
Global
Comparative charts on Drugs, Brands, Market data, Investment Bank Forecasts, Complete Data Base and Archives, Court, all published reports “Drugs in depth”, NetworkmedicaTV.com*
» more details
All Networkmedica.com, Investments Banks Forecasts, Drugs and Pipeline analysis in the Pharma and Biotech industry, Drugs in-depth, Drugs Comparative (by therapeutic area, family, and revenue year) Maket Data, Experts Opinions, Brands, Complete access to search tool, archives, transcripts (1) Judgements of the court, Videos (NetworkmedicaTV*) Advanced search, access to archives and previous editions.

Daily: 3,28 (U.S. Dollars)

Subcriptions recommended for professionals


*Available during 2009 (1) Main data
Global (Annual) - $700
To subscribe please complete the form below.
  Personal information * Required field  
* Name
* User name
* Last name
* Password
Address * Confirm password
City
Zip code
State
* Country:
* Birth date (day,month,year)
* Phone
(please add international and area code)
   
Mobile
(please add international and area code)
   
Fax
Invoice or billing information
Name:
Tax information
(CUIT, NIF, RUC, CIF, etc.)
Other data
Company
Business Type
* Position
* e-mail
No massive mails allowed (ex hotmail, yahoo, gmal or similars)